SCHEMBL29401397

SCHEMBL29401397

CCCCCCCCC(=O)NOC1CCCCO1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.43
TP53 P04637 1/20 0.41
HPGD P15428 1/20 0.41
ALOX12 P18054 1/20 0.41
CNR1 P21554 3/20 0.41
CNR2 P34972 3/20 0.41
MEN1 O00255 1/20 0.41
FAAH O00519 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 1/20 0.41
CCR2 P41597 1/20 0.40
TRPV1 Q8NER1 4/20 0.40
HSP90AA1 P07900 1/20 0.40
GNAI3 P08754 1/20 0.40
GNAO1 P09471 1/20 0.40
GNAI1 P63096 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29870434 1.00 NAAA (0.43) NAAATP53HPGDALOX12CNR1
SCHEMBL10704937 1.00 NAAA (0.43) NAAATP53HPGDALOX12CNR1
SCHEMBL29400724 0.99 NAAA (0.41) NAAATP53HPGDALOX12CNR1
SCHEMBL29397580 0.94 USP2 (0.38) NAAATP53HPGDALOX12MEN1
SCHEMBL30985368 0.89 TP53 (0.43) TP53HPGDALOX12CNR1CNR2
SCHEMBL30985315 0.89 TP53 (0.43) TP53HPGDALOX12CNR1CNR2
SCHEMBL30985338 0.89 TP53 (0.43) TP53HPGDALOX12CNR1CNR2
SCHEMBL16569372 0.88 ALDH1A1 (0.39) HPGDMEN1KMT2A
SCHEMBL20764812 0.88 ALDH1A1 (0.39) HPGDMEN1KMT2A
SCHEMBL13771143 0.87 TP53 (0.42) TP53HPGDALOX12MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112920167-B Double-target inhibitor targeting FGFR and HDAC, preparation method and application thereof, pharmaceutical composition and medicament 四川大学华西医院 2022-08-26 CN disclosed
WO-2022037365-A1 DOUBLE-TARGET INHIBITOR TARGETING FGFR AND HDAC, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITION AND MEDICAMENT 四川大学华西医院 2022-02-24 WO disclosed